Actiste®, currently being introduced to the global market by
The annual awards take place at Mobile World Congress Barcelona, and spotlight the most innovative telecoms solutions from industry heavyweights.
Actiste is the world's first complete IoT care solution for monitoring and treating insulin-dependent diabetes. The unit brings together and combine all the necessary functions for diabetes care - blood sampling, blood glucose measurement and drug injection - in a single connected device.
The solution is based on patented technology for collecting data on specified biomarkers and injected volumes of drugs. With state-of-the-art eSIM technology, provided by the industry leading ICT company
The Actiste device is delivered as part of a subscription service. The service includes global connectivity, different levels of data sharing, continuous replenishment of consumables and enables coaching to optimize and improve treatment. https://actiste.com/
For further information, please contact:
Henrik Norström, CEO
+46 733 40 30 45
henrik.norstrom@brighter.se
About
Brighter is a health-tech company from
The Company's shares are listed on Nasdaq First North Growth Market/BRIG.Brighter's Certified Adviser on Nasdaq OMX First North is
https://news.cision.com/brighter-ab--publ-/r/brighter-s-actiste-shortlisted-for-mwc2020-glomo-awards---best-mobile-innovation-for-health-and-biot,c3016503
https://mb.cision.com/Main/13292/3016503/1180441.pdf
(c) 2020 Cision. All rights reserved., source